A randomised study comparing the antiplatelet and antiinflammatory effect of clopidogrel 150 mg/day versus 75 mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: results from the DOUBLE study.
Published Apr 1, 2010 · T. Palmerini, C. Barozzi, L. Tomasi
Thrombosis research
51
Citations
1
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayIn patients with STEMI and poor responsiveness to clopidogrel, a 150 mg daily maintenance dose significantly reduces platelet aggregation and shows a trend towards reduced inflammation.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.